Skip to main content

T Dua

First name:
T
Last name:
Dua
Meyer, A., Dua, T., Boscardin, W., Escarce, J., Saxena, S., & Birbeck, G. (2012). Critical determinants of the epilepsy treatment gap: a cross-national analysis in resource-limited settings. Epilepsia, 53(12), 2178-85. https://doi.org/10.1111/epi.12002
Meyer, A., Dua, T., Ma, J., Saxena, S., & Birbeck, G. (2010). Global disparities in the epilepsy treatment gap: a systematic review. Bulletin of the World Health Organization, 88(4), 260-6. https://doi.org/10.2471/BLT.09.064147
Barbui, C., Dua, T., van Ommeren, M., Yasamy, M., Fleischmann, A., Clark, N., … Saxena, S. (2010). Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders. PLoS Medicine, 7(8). https://doi.org/10.1371/journal.pmed.1000322 (Original work published 2010)
Maulik, P., Mascarenhas, M., Mathers, C., Dua, T., & Saxena, S. (1969). Prevalence of intellectual disability: a meta-analysis of population-based studies. Research in Developmental Disabilities, 32(2), 419-36. https://doi.org/10.1016/j.ridd.2010.12.018 (Original work published 1969)
van Ommeren, M., Barbui, C., de Jong, K., Dua, T., Jones, L., Perez-Sales, P., … Saxena, S. (2011). If you could only choose five psychotropic medicines: updating the interagency emergency health kit. PLoS Medicine, 8(5), e1001030. https://doi.org/10.1371/journal.pmed.1001030
Reed, G., Dua, T., & Saxena, S. (2011). World Health Organization responds to Fiona Godlee and Ray Moynihan. BMJ (Clinical Research Ed.), 342, d3830. https://doi.org/10.1136/bmj.d3830 (Original work published 2011)
Steiner, T., Stovner, L., Dua, T., Birbeck, G., Jensen, R., Katsarava, Z., … Saxena, S. (2011). Time to act on headache disorders. The Journal of Headache and Pain, 12(5), 501-3. https://doi.org/10.1007/s10194-011-0368-7
Dua, T., Barbui, C., Clark, N., Fleischmann, A., , van Ommeren, M., … Saxena, S. (2011). Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations. PLoS Medicine, 8(11), e1001122. https://doi.org/10.1371/journal.pmed.1001122
Cameron, A., Bansal, A., Dua, T., , Moshé, S., Mantel-Teeuwisse, A., & Saxena, S. (2012). Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries. Epilepsia, 53(6), 962-9. https://doi.org/10.1111/j.1528-1167.2012.03446.x
Mateen, F., Dua, T., Shen, G., Reed, G., Shakir, R., & Saxena, S. (2012). Neurological disorders in the 11th revision of the International Classification of Diseases: now open to public feedback. The Lancet. Neurology, 11(6), 484-5. https://doi.org/10.1016/S1474-4422(12)70125-4